148459-54-5Relevant articles and documents
BICYCLIC INHIBITORS OF ALK
-
, (2014/06/25)
The present invention relates to compounds of formula (1) or pharmaceutical acceptable salts, Formula (1) wherein R1, R2, R3, X, Y, Z, A, B, G1, m, and n are defined in the description. The present invention relates also to compositions containing said compounds which are useful for inhibiting kinases such as ALK and methods of treating diseases such as cancer.
Synthesis and preliminary evaluation of curcumin analogues as cytotoxic agents
Zhang, Qin,Zhong, Ying,Yan, Lin-Na,Sun, Xun,Gong, Tao,Zhang, Zhi-Rong
scheme or table, p. 1010 - 1014 (2011/03/21)
A series of curcumin analogues with different substituents at the 4-position of the phenyl group were synthesized and screened for in vitro cytotoxicity against a panel of human cancer cell lines. Several novel curcumin analogues, especially 32 and 34, exhibited selective and potent cytotoxic activity against human epidermoid carcinoma cell line A-431 and human glioblastoma cell line U-251, implying their specific potential in the chemoprevention and chemotherapy of skin cancer and glioma. The preliminary SAR information extracted from the results suggested that introduction of appropriate substituents to the 4′-positions could be a promising approach for the development of new cytotoxic curcumin analogues with special selectivity for A-431 and U-251 cell lines.
Trifluoromethyl-substituted hydantoins, versatile building blocks for rational drug design
Wehner, Volkmar,Stilz, Hans-Ulrich,Osipov, Sergej N.,Golubev, Alexander S.,Sieler, Joachim,Burger, Klaus
, p. 4295 - 4302 (2007/10/03)
Preparatively simple, one-pot syntheses of trifluoromethyl-substituted hydantoins starting from Boc-protected imines of hexafluoroacetone and trifluoropyruvate are described. They represent valuable building blocks for the construction of constrained pept